drugset / Trial / NCT06619951

A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects

NCT06619951 ↗

Phase 1 Completed 56 enrolled Jiangsu vcare pharmaceutical technology co., LTD
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will adopt a Single-center, Single-arm, Open, Fixed Sequence design to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects.

Timeline

Start
2024-09-18
Primary completion
2024-10-31
Completion
2024-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — —
Subject Rifampicin Small molecule — —
Subject VC004 Unknown — —

Indications

No indication recorded.